Your browser doesn't support javascript.
loading
Extracellular proteasome-osteopontin circuit regulates cell migration with implications in multiple sclerosis.
Dianzani, Chiara; Bellavista, Elena; Liepe, Juliane; Verderio, Claudia; Martucci, Morena; Santoro, Aurelia; Chiocchetti, Annalisa; Gigliotti, Casimiro Luca; Boggio, Elena; Ferrara, Benedetta; Riganti, Loredana; Keller, Christin; Janek, Katharina; Niewienda, Agathe; Fenoglio, Chiara; Sorosina, Melissa; Cantello, Roberto; Kloetzel, Peter M; Stumpf, Michael P H; Paul, Friedemann; Ruprecht, Klemens; Galimberti, Daniela; Martinelli Boneschi, Filippo; Comi, Cristoforo; Dianzani, Umberto; Mishto, Michele.
Afiliação
  • Dianzani C; Department of Drug Science and Technology, University of Turin, 10126 Torino, Italy.
  • Bellavista E; Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, 40126 Bologna, Italy.
  • Liepe J; Centre for Integrative Systems Biology and Bioinformatics, Department of Life Sciences, Imperial College London, SW7 2AZ London, UK.
  • Verderio C; Institute of Neuroscience, Centro Nazionale delle Ricerche (CNR), 20129 Milano, Italy.
  • Martucci M; IRCCS Humanitas, 20089 Rozzano, Italy.
  • Santoro A; Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, 40126 Bologna, Italy.
  • Chiocchetti A; Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, 40126 Bologna, Italy.
  • Gigliotti CL; Interdisciplinary Research Centre of Autoimmune Diseases (IRCAD), University of Piemonte Orientale, Amedeo Avogadro, 28100 Novara, Italy.
  • Boggio E; Interdisciplinary Research Centre of Autoimmune Diseases (IRCAD), University of Piemonte Orientale, Amedeo Avogadro, 28100 Novara, Italy.
  • Ferrara B; Interdisciplinary Research Centre of Autoimmune Diseases (IRCAD), University of Piemonte Orientale, Amedeo Avogadro, 28100 Novara, Italy.
  • Riganti L; Department of Drug Science and Technology, University of Turin, 10126 Torino, Italy.
  • Keller C; Institute of Neuroscience, Centro Nazionale delle Ricerche (CNR), 20129 Milano, Italy.
  • Janek K; Institut für Biochemie, Charité - Universitätsmedizin Berlin, 10117 Berlin, Germany.
  • Niewienda A; Berlin Institute of Health, 10117 Berlin, Germany.
  • Fenoglio C; Institut für Biochemie, Charité - Universitätsmedizin Berlin, 10117 Berlin, Germany.
  • Sorosina M; Institut für Biochemie, Charité - Universitätsmedizin Berlin, 10117 Berlin, Germany.
  • Cantello R; Neurology Unit, Department of Pathophysiology and Transplantation, University of Milan, "Dino Ferrari" Centre, Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico, 20100 Milano, Italy.
  • Kloetzel PM; Department of Neuro-rehabilitation and Laboratory of genetics of Neurological complex disorders, Institute of Experimental Neurology (INSPE) Scientific Institute San Raffaele, 20132 Milano, Italy.
  • Stumpf MP; Department of Translational Medicine, Section of Neurology, University of Piemonte Orientale, 28100 Novara, Italy.
  • Paul F; Institut für Biochemie, Charité - Universitätsmedizin Berlin, 10117 Berlin, Germany.
  • Ruprecht K; Berlin Institute of Health, 10117 Berlin, Germany.
  • Galimberti D; Centre for Integrative Systems Biology and Bioinformatics, Department of Life Sciences, Imperial College London, SW7 2AZ London, UK.
  • Martinelli Boneschi F; AG Klinische Neuroimmunologie des Neurocure Clinical Research Center, Charité - Universitätsmedizin Berlin, 10117 Berlin, Germany.
  • Comi C; Clinical and Experimental Multiple Sclerosis Research Centre - Universitätsmedizin Berlin, 10117 Berlin, Germany.
  • Dianzani U; Experimental and Clinical Research Center, Max Delbrueck Center for Molecular Medicine and Charité - Universitaetsmedizin Berlin, Berlin, Germany.
  • Mishto M; Clinical and Experimental Multiple Sclerosis Research Centre - Universitätsmedizin Berlin, 10117 Berlin, Germany.
Sci Rep ; 7: 43718, 2017 03 09.
Article em En | MEDLINE | ID: mdl-28276434
ABSTRACT
Osteopontin is a pleiotropic cytokine that is involved in several diseases including multiple sclerosis. Secreted osteopontin is cleaved by few known proteases, modulating its pro-inflammatory activities. Here we show by in vitro experiments that secreted osteopontin can be processed by extracellular proteasomes, thereby producing fragments with novel chemotactic activity. Furthermore, osteopontin reduces the release of proteasomes in the extracellular space. The latter phenomenon seems to occur in vivo in multiple sclerosis, where it reflects the remission/relapse alternation. The extracellular proteasome-mediated inflammatory pathway may represent a general mechanism to control inflammation in inflammatory diseases.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Complexo de Endopeptidases do Proteassoma / Osteopontina / Esclerose Múltipla Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Complexo de Endopeptidases do Proteassoma / Osteopontina / Esclerose Múltipla Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article